Filing Details

Accession Number:
0001753763-19-000001
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-25 17:36:11
Reporting Period:
2019-03-22
Accepted Time:
2019-03-25 17:36:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
810509 Navidea Biopharmaceuticals Inc. NAVB In Vitro & In Vivo Diagnostic Substances (2835) 311080091
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1753763 Jr. K John Scott 5251 Dtc Parkway, Suite 285
Greenwood Village CO 80111
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-03-22 357,143 $0.14 22,261,565 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 52,785 Indirect By Spouse
Common Stock 50,000 Indirect By Daughter
Common Stock 50,000 Indirect By Son
Common Stock 50,000 Indirect By Son
Footnotes
  1. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.